Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, August 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#41 of 2,501)
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 1 news outlet
patent: 3 patents

wikipedia: 4 Wikipedia pages

Citations

dimensions_citation: 165 Dimensions

Readers on

mendeley: 63 Mendeley

Summary News Patents Wikipedia Dimensions citations

So far, Altmetric has seen 1 news story.

Targeted Drugs May Help in Rare Adrenal Cancer (CME/CE)

MedPage Today, 09 Dec 2013

(MedPage Today) -- A rare but deadly endocrine malignancy with no effective drug treatments may respond to targeted therapies…